Treatment of cultured mouse CF with the TRPM7 inhibitor 2-aminoethoxydiphenylborate (2-APB) attenuated Ang II-induced upregulation of connective tissue growth factor (CTGF) and α-SMA, and inhibited CF proliferation [133]. This evidence concerns the gene ACTA1 and cystic fibrosis.